Cached score snapshot

US.DGX · Quest Diagnostics

110分制 55.1/110;5D動能v2 20/50;排序分 75.1/160

Ranking score 75.1/160
Main score 55.1/110
5D momentum v2 20/50
Rank #66
Setup grade D 35

Score breakdown

觀望

Medium database-backfill

Score and price trend

D 35 Low sample confidence

Main score, 5D momentum v2, close price, and improving or exit-review turn signals are plotted from archived daily snapshots.

Move the mouse over the chart lines to inspect readings.

0 40 80 110 Score 01-02 02-20 04-09 05-27 07-09 $167.34$195.19$223.04 Price Projection date
Historical projection
Model Median P25/P75 歷史相似情境上漲比例 Down5 Actual / compare
Rolling DOE best · score 2.678 · anchors 20 -0.32% -2.37% / +1.52% 47.5% 10.8% Actual -4.20% · vs median -3.88% · inside 25-75 band
Historical projection 10D n=160 +0.26% -1.82% / +1.87% 53.8% 8.1% Actual -2.00% · vs median -2.26% · inside 25-75 band

歷史情境統計基於已存檔相似 setup;圖中投影中位線為統計中位數的線性插值展示,並非價格路徑預測或買賣建議。

2026-01-02 → 2026-07-09 · 129 archived points

Summary

score_with_momentum_v2 = main score + 5D momentum v2

Ranking score 75.1
Display grade 觀望
Model version cursor_18_27_news_v2_160
Main score 55.1/110 (觀望)
5D momentum v2 20/50 (中)
Score with momentum v2 75.1/160 (低排序)
Risk level Medium

Audit trace

Full calculation detail

Calculation detail · 8 sections

Market inputs

Bar count 145
ma20 178.6655
ma50 182.0142
close 188.95
prevClose 189.49
avgVolume20 897400
volumeRatio 1.65
changePercent -0.28

Metrics snapshot

close 188.95
volume 1482000
changePercent -0.28

110-point main rating

基本面5 + 資金流20 + 市場環境15 + 催化劑20 + 風險管理10 + 技術信號30 + 情緒10

Main score 55.1/110
Main rating 觀望
5D momentum v2 20/50
Score with momentum v2 75.1/160
Formula score_with_momentum_v2 = main_score + momentum_5d_v2_score

基本面 — 3.7/5 · 良好

Dimension score 3.7/5
Dimension grade 良好

Sub-items

pbPoints 0.4
pePoints 0.4
epsPoints 0.4
roePoints 0.4
debtPoints 0.4
marginPoints 0
turnoverUsdM 280.0239
volumePoints 0.5
revenuePoints 0.4
dividendPoints 0.3
marketCapPoints 0.5

資金流 — 11.6/20 · 較差

Dimension score 11.6/20
Dimension grade 較差

Sub-items

cmfPoints 2.4
mfiPoints 2.4
obvPoints 0.8
vwapPoints 4

institutional

score 2

details

source optional-neutral

warning

code INSTITUTIONAL_DATA_OPTIONAL
symbol US.DGX
message Institutional ownership is unavailable; neutral 2/4 money-flow treatment used.
optional true
holderCount n/a
holderPoints 2
top10ShareRatio n/a
concentrationPenalty 0
institutionPoints 2

市場環境 — 9/15 · 一般

Dimension score 9/15
Dimension grade 一般

Sub-items

vix

score 1.8

details

source twelvedata+fred+database-backfill-market-proxy
vixClose 20.09

trend

score 3.4

details

qqq

ma20 121.9847
ma50 119.4142
name QQQ
close 120.0299
points 1.4

spy

ma20 112.5335
ma50 110.2373
name SPY
close 112.7733
points 2
source twelvedata+fred+database-backfill-market-proxy
atrPct 2.0319
atrPoints 3
cciPoints 0.8
vixPoints 1.8
marketTrendPoints 3.4

催化劑 — 2/20 · 較差

Dimension score 2/20
Dimension grade 較差

Sub-items

catalyst

score 2

details

source finnhub_news_keyword_model
articleCount 5
catalystCount 0
catalystPoints 2

風險管理 — 7.4/10 · 良好

Dimension score 7.4/10
Dimension grade 良好

Sub-items

position

score 1.6

details

atrPct 2.0319
turnoverUsdM 280.0239
liquidityPoints 0.6
volatilityPoints 1
rrPoints 1.4

stopLevels

symbol US.DGX
rr_range 1:1.0-1:2.5
risk_profile 中等
stop_loss_price 181.2714

strength_details

ma_score 1
atr_score 2
rsi_score 0.5
macd_score 3
volume_score 2
market_adjustment 1
risk_reward_ratio 1.2
stop_loss_percent 4.1
take_profit_price 198.3975
target_multiplier 1.9
technical_strength 1.75
take_profit_percent 5
positionPoints 1.6
stopLossPoints 2.4

diversification

score 2

details

method sector concentration proxy; no portfolio holdings used
sector Health Care
concentratedSectorPenalty 0
riskRewardRatio 1.2304
stopLossPercent 4.0638
diversificationPoints 2

技術信號 — 18.4/30 · 一般

Dimension score 18.4/30
Dimension grade 一般

Sub-items

bbPoints 3
adxPoints 3
sarPoints 2.4
vcpPoints 0.9
macdPoints 4

vcpPayload

vcp_pass false
vcp_score 0.9
vcp_reason 站上MA50;升放量(近10日4日);Ready=N;Confirm=N

vcp_metrics

up_days 5
vol_ref 929630
down_days 4
vcp_ready false
above_ma50 true
avg_vol_10 1013580
avg_vol_20 871990
avg_vol_30 929630
range_pct_10 0.1048
range_pct_20 0.1048
range_pct_30 0.1048
up_expand_ok true
lookback_used 79
near_20d_high true
contraction_ok false
down_shrink_ok false
up_expand_days 4
breakout_20d_ok false
vol_ratio_10_30 1.0903
dist_to_20d_high 0.0107
down_shrink_days 2
breakout_level_20d 190.99
vcp_breakout_confirm false
contraction_ratio_10_30 1
vcp_name_en Volatility Contraction Pattern
vcp_name_zh 波動收縮形態
vol_contraction false
kdjAdxPoints 0.7
rsiKdjPoints 2.4
volumeWeight 2
maCrossPoints 0
shortRsiPoints 0.4
shortMacdPoints 0.4
volConfirmPoints 0
volumePointsTechnical 1.2

情緒分析 — 3/10 · 較差

Dimension score 3/10
Dimension grade 較差

Sub-items

sentiment

score 3

details

source finnhub_news_keyword_model
articleCount 5
negativeHits 0
positiveHits 1
sentimentScoreRaw 0.5

sentimentData

raw {"id":140615840,"url":"https://finnhub.io/api/news?id=7a05145bb3efb646e93dac1f0de09e97ba5cca4144e93d6c03b19c31c4663b96","image":"https://www.chartmill.com/images/uploads/Best_Dividend_500_264px_webp_9524a3945f.webp","source":"ChartMill","related":"DGX","summary":"Quest Diagnostics (DGX) offers a 1.75% dividend yield with strong 7.42% annual growth. Featuring a sustainable 35% payout ratio and solid profitability, this stock balances reliable income with financial stability.","category":"company","datetime":1781255440,"headline":"Quest Diagnostics Inc (NYSE:DGX): A Top Dividend Stock with Sustainable Income and Growth Potential"}, {"id":140525740,"url":"https://finnhub.io/api/news?id=b6e2bb6fd8edc2cbeb62be5f1f745e81049b3943c34ac194c362fabb2300bba5","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"DGX","summary":"Quest Diagnostics is in focus today as the latest update shows no changes to the current price targets set by covering analysts. Even without fresh commentary driving the story, the lack of adjustment itself can be useful context as you think about how the stock fits into your watchlist or portfolio. Read on to see how to monitor future shifts in the analyst narrative so you can stay on top of what changes and what stays the same. Wall Street's queuing for one rocket. While SpaceX counts down...","category":"company","datetime":1780592890,"headline":"How The Quest Diagnostics (DGX) Investment Story Is Evolving Without New Analyst Price Target Changes"}, {"id":140460566,"url":"https://finnhub.io/api/news?id=5ee75f7ec4104dac24b2e468a1a398513a80b7f1280003cf01ea79f11012230e","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"DGX","summary":"Quest Diagnostics (DGX) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.","category":"company","datetime":1780070404,"headline":"Quest Diagnostics (DGX) Upgraded to Buy: Here's What You Should Know"}, {"id":140447040,"url":"https://finnhub.io/api/news?id=76fa090f28882e13396e37f10e3432b5d04a945f44a80319e578848ce3e5f679","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"DGX","summary":"Since November 2025, Quest has been in a holding pattern, posting a small return of 2.6% while floating around $194.06. The stock also fell short of the S&P 500’s 9.8% gain during that period.","category":"company","datetime":1779989187,"headline":"3 Reasons to Sell DGX and 1 Stock to Buy Instead"}, {"id":140421419,"url":"https://finnhub.io/api/news?id=f865a9a57f7dd61d98179f034b0e6aea3ce3f70dd23d597cc203834196aec7f1","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"DGX","summary":"Here is how Quest Diagnostics (DGX) and DaVita HealthCare (DVA) have performed compared to their sector so far this year.","category":"company","datetime":1779802801,"headline":"Are Medical Stocks Lagging Quest Diagnostics (DGX) This Year?"}
raw_source {"id":140668871,"url":"https://finnhub.io/api/news?id=08a165bfc9d22174df2b848db02f7eb78726040bc8f617e12f26030cdc3b4bd5","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"DGX","summary":"While Quest Diagnostics has lagged behind the S&P 500 Index over the past year, analysts are moderately optimistic about the stock’s prospects.","category":"company","datetime":1781838718,"headline":"Is Quest Diagnostics Stock Underperforming the S&P 500?"}, {"id":140665236,"url":"https://finnhub.io/api/news?id=10a66dda14b20e65fc5be2ae6f7932dd68373d8b45a9c33eed65c7ea20cc6dbe","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"DGX","summary":"Labcorp Holdings has underperformed the Nasdaq over the past year, but analysts are highly optimistic about the stock’s prospects.","category":"company","datetime":1781789504,"headline":"Is Labcorp Holdings Stock Underperforming the Nasdaq?"}, {"id":140662649,"url":"https://finnhub.io/api/news?id=a3ddc6fc60a25650a6a7b7ec00f1098550bdd259930a161fd2522e1fd6aaeaee","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"DGX","summary":"A common bacterial strain that lives naturally in people's guts can cause a dangerous or deadly infection for some, especially when it becomes multidrug-resistant and causes chronic urinary-tract infections (UTIs) in elderly women. But the extent of its effect on the broader population and its prevalence in the community was not well known – until now.","category":"company","datetime":1781787420,"headline":"UTI-causing Bacteria Resistant to Current Drugs, Finds National Study by Hackensack Meridian CDI and Quest Diagnostics"}, {"id":140652802,"url":"https://finnhub.io/api/news?id=a2d1114a3464516682d5c89b546eb31ebc0c8cf8a5790a0e30e3eaea95e07646","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"DGX","summary":"Quest Diagnostics Incorporated (NYSE: DGX), a leader in diagnostic information services, announced today that it will report its second quarter 2026 financial results on Thursday, July 23, 2026, before the market opens. It will hold its quarterly conference call to discuss the results beginning at 8:30 a.m. Eastern Time on that day.","category":"company","datetime":1781701200,"headline":"Quest Diagnostics to Release Second Quarter Financial Results on July 23, 2026"}, {"id":140645122,"url":"https://finnhub.io/api/news?id=02545c56786bbb69e32353ee74b7b0c8716b762e706b90b0f64b40239d51d26e","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"DGX","summary":"Quest Diagnostics (NYSE: DGX), a leader in diagnostic information services, today unveiled its 2025 Corporate Responsibility Report.","category":"company","datetime":1781614800,"headline":"Quest Diagnostics Unveils Achievements in Healthcare Access, Employee Engagement and Environmental Sustainability in 2025 Corporate Responsibility Report"}, {"id":140645123,"url":"https://finnhub.io/api/news?id=f6eb967deba60429c3484684beb7ee44db64e94e7fe5eb8e4629bd0c8f289fd2","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"DGX","summary":"GAITHERSBURG, Md., June 16, 2026--GeneDx today announced the appointment of Mark Gardner as President, effective June 15, 2026.","category":"company","datetime":1781613000,"headline":"GeneDx Names Mark Gardner President to Lead Its Next Phase of Scale and Growth"}, {"id":140615840,"url":"https://finnhub.io/api/news?id=7a05145bb3efb646e93dac1f0de09e97ba5cca4144e93d6c03b19c31c4663b96","image":"https://www.chartmill.com/images/uploads/Best_Dividend_500_264px_webp_9524a3945f.webp","source":"ChartMill","related":"DGX","summary":"Quest Diagnostics (DGX) offers a 1.75% dividend yield with strong 7.42% annual growth. Featuring a sustainable 35% payout ratio and solid profitability, this stock balances reliable income with financial stability.","category":"company","datetime":1781255440,"headline":"Quest Diagnostics Inc (NYSE:DGX): A Top Dividend Stock with Sustainable Income and Growth Potential"}, {"id":140594190,"url":"https://finnhub.io/api/news?id=fe13425cb83a2200bec8c0a082ede13f10cef8dcd706a56d10cff8412575574d","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"DGX","summary":"Quest Diagnostics, DaVita, LifeStance Health and Aveanna Healthcare are benefiting from telehealth, AI adoption and growing home-care demand.","category":"company","datetime":1781097720,"headline":"Zacks Industry Outlook Highlights Quest Diagnostics, DaVita, LifeStance Health and Aveanna Healthcare"}, {"id":140581606,"url":"https://finnhub.io/api/news?id=9bb8e271a7af0c14ca05659cc4848cc2352964d67cf4361222aad63995e29041","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"DGX","summary":"An aging population and rising telehealth and AI adoption boost demand in the Zacks Medical - Outpatient and Home Healthcare industry. DGX, DVA, LFST and AVAH stand to benefit.","category":"company","datetime":1781016000,"headline":"4 Outpatient Home Health Stocks Benefiting From Industry Trends"}, {"id":140535106,"url":"https://finnhub.io/api/news?id=c57369c47aa907aaf1780d15a262ad0b4f4f1dab02017c63aa94889e370381aa","image":"https://www.chartmill.com/images/uploads/CM_Premarket_Movers_Small_free_90289f6b81.webp","source":"ChartMill","related":"DGX","summary":"Before the US market kicks off on Friday, let's examine the pre-market session and unveil the notable performers among the S&P500 top gainers and losers.","category":"company","datetime":1780662900,"headline":"Top S&P500 movers in Friday's pre-market session"}, {"id":140525740,"url":"https://finnhub.io/api/news?id=b6e2bb6fd8edc2cbeb62be5f1f745e81049b3943c34ac194c362fabb2300bba5","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"DGX","summary":"Quest Diagnostics is in focus today as the latest update shows no changes to the current price targets set by covering analysts. Even without fresh commentary driving the story, the lack of adjustment itself can be useful context as you think about how the stock fits into your watchlist or portfolio. Read on to see how to monitor future shifts in the analyst narrative so you can stay on top of what changes and what stays the same. Wall Street's queuing for one rocket. While SpaceX counts down...","category":"company","datetime":1780592890,"headline":"How The Quest Diagnostics (DGX) Investment Story Is Evolving Without New Analyst Price Target Changes"}, {"id":140525741,"url":"https://finnhub.io/api/news?id=a1bf00dc6631b26eca5d16cb6f543b49929f4df34a2acc38cb31b2b6ca08fa8b","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"DGX","summary":"DaVita HealthCare (DVA) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.","category":"company","datetime":1780587012,"headline":"DaVita HealthCare (DVA) Up 0.6% Since Last Earnings Report: Can It Continue?"}, {"id":140486850,"url":"https://finnhub.io/api/news?id=9aa04f5b5fbf5aa0c2ffc3af4c508d1720ce92f4d02c51a44b98134b51b03e09","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"DGX","summary":"EHC is expanding its rehabilitation network with a new 36-bed hospital in West Virginia.","category":"company","datetime":1780315740,"headline":"Encompass Health to Expand WV Footprint With 36-Bed Bridgeport Unit"}, {"id":140460566,"url":"https://finnhub.io/api/news?id=5ee75f7ec4104dac24b2e468a1a398513a80b7f1280003cf01ea79f11012230e","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"DGX","summary":"Quest Diagnostics (DGX) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.","category":"company","datetime":1780070404,"headline":"Quest Diagnostics (DGX) Upgraded to Buy: Here's What You Should Know"}, {"id":140447040,"url":"https://finnhub.io/api/news?id=76fa090f28882e13396e37f10e3432b5d04a945f44a80319e578848ce3e5f679","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"DGX","summary":"Since November 2025, Quest has been in a holding pattern, posting a small return of 2.6% while floating around $194.06. The stock also fell short of the S&P 500’s 9.8% gain during that period.","category":"company","datetime":1779989187,"headline":"3 Reasons to Sell DGX and 1 Stock to Buy Instead"}, {"id":140421419,"url":"https://finnhub.io/api/news?id=f865a9a57f7dd61d98179f034b0e6aea3ce3f70dd23d597cc203834196aec7f1","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"DGX","summary":"Here is how Quest Diagnostics (DGX) and DaVita HealthCare (DVA) have performed compared to their sector so far this year.","category":"company","datetime":1779802801,"headline":"Are Medical Stocks Lagging Quest Diagnostics (DGX) This Year?"}, {"id":140413445,"url":"https://finnhub.io/api/news?id=ae610d13ba08036a4003a9833ecc4cb745d5da2b4a568427191a590b2d4807f0","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"DGX","summary":"Quest Diagnostics is keeping analysts reasonably upbeat as steady execution and momentum continue supporting Wall Street confidence.","category":"company","datetime":1779712356,"headline":"Quest Diagnostics Stock: Analyst Estimates & Ratings"}, {"id":140397951,"url":"https://finnhub.io/api/news?id=714544268cb0481d8b078b9c8724263249e73d28d3824cb2fc661958e6c22ccc","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"DGX","summary":"Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today doesn’t mean it will thrive tomorrow.","category":"company","datetime":1779542215,"headline":"1 Profitable Stock to Own for Decades and 2 We Avoid"}
data_source finnhub_news_keyword_model
article_count 5
negative_hits 0
positive_hits 1
recomputed_at_score true
sentiment_score_raw 0.5
source_article_count 18
discarded_article_count 13
sentimentPoints 3

Dimension contribution

Dimension Raw Max Norm % Contrib
基本面 3.7 5/110 74% 3.7
資金流 11.6 20/110 58% 11.6
市場環境 9 15/110 60% 9
催化劑 2 20/110 10% 2
風險管理 7.4 10/110 74% 7.4
技術信號 18.4 30/110 61.33% 18.4
情緒分析 3 10/110 30% 3

5D momentum v2 breakdown

Cursor_18.25 5D momentum v2 0-50

5D momentum v2 20/50
ret_5d 0.0739
max_score 50
max_total 50
raw_total 20
vcp_bonus 0
vol_ratio 1.6996
ret_points 12
vol_points 6
range_ratio 1.2744
volat_points 2
day_range_pct 0.0224
model_version cursor_18_27_news_v2_160
available_bars 30
breakout_points 0
partial_history false
pullback_points 0
breakout_vol_bonus 0
first_breakout_20d false
return_window_days 5
first_breakout_bonus 0
breakout_quality_points 0

Risk management

level Medium
reason risk management score >= 6.5/10

position

score 1.6

details

atrPct 2.0319
turnoverUsdM 280.0239
liquidityPoints 0.6
volatilityPoints 1
rrPoints 1.4

stopLevels

symbol US.DGX
rr_range 1:1.0-1:2.5
risk_profile 中等
stop_loss_price 181.2714

strength_details

ma_score 1
atr_score 2
rsi_score 0.5
macd_score 3
volume_score 2
market_adjustment 1
risk_reward_ratio 1.2
stop_loss_percent 4.1
take_profit_price 198.3975
target_multiplier 1.9
technical_strength 1.75
take_profit_percent 5
positionPoints 1.6
stopLossPoints 2.4

diversification

score 2

details

method sector concentration proxy; no portfolio holdings used
sector Health Care
concentratedSectorPenalty 0
riskRewardRatio 1.2304
stopLossPercent 4.0638
diversificationPoints 2

Calculation audit log

基本面分析總分: 3.7/5分
資金流分析總分: 11.6/20分
市場環境分析總分: 9/15分
催化劑分析: 2/20分
風險管理總分: 7.4/10分
技術信號分析總分: 18.4/30分
情緒分析: 3/10分
共振率(僅顯示不加分): 0%

Technical indicators

adx
value 92.86
atr
atr 3.8393
rule ATR / current price; lower volatility scores higher
score 6
atr_pct 2.03
cci
rule Cursor_18.24 CCI bands
level 超買或超賣風險
score 2
value 177.5
cmf
rule Cursor_18.24 CMF bands
level 輕微流入
score 6
value 0.1452
kdj
d 76.98
j 103.35
k 85.77
rule Cursor_18.24 K/D cross
score 4
signal 金叉
mfi
rule Cursor_18.24 MFI bands
level 平衡
score 6
value 56.25
obv
rule Cursor_18.24 recent_slope vs previous_slope
score 2
trend 資金流出
value -5923400
recentSlope -68500
previousSlope -15930
rsi
value 70.55
sar
rule Cursor_18.24 Parabolic SAR
score 8
trend 上升
value 176.6378
position SAR喺價下
distancePct 6.52
previousTrend 上升
ma50
value 182.0142
macd
macd 1.8204
trend 強烈看漲
signal -0.0638
histogram 1.8842
vwap
rule Cursor_18.24 VWAP 20D consecutive close
score 10
value 179.7256
position 連續5日>VWAP
consecutiveAbove 5
volume
rule Cursor_18.24 volume ratio
level 有量
ratio 1.65
score 6
avgVolume 897400
currentVolume 1482000
derived
ma20 178.6655
ma50 182.0142
prevClose 189.49
avgVolume10 1086900
avgVolume20 897400
changePercent -0.28
avgVolumeForScore 897400
ma_cross
ma20 178.6655
ma50 182.0142
rule Cursor_18.24 MA20/MA50 cross
cross 熊勢
score 0
prevMa20 178.0255
prevMa50 181.8004
spreadPct 1.84
isVolumeBreakout false
bollinger
lower 167.7908
upper 189.5402
position 上半部
rsi_short
value 92.35
macd_short
macd 0
trend 中性
signal 0
histogram 0
volume_ratio
ratio 1.65

Raw calculation JSON

{
  "risk": {
    "level": "Medium",
    "reason": "risk management score >= 6.5/10",
    "position": {
      "score": 1.6,
      "details": {
        "atrPct": 2.031913204551469,
        "turnoverUsdM": 280.0239,
        "liquidityPoints": 0.6,
        "volatilityPoints": 1
      }
    },
    "rrPoints": 1.4,
    "stopLevels": {
      "symbol": "US.DGX",
      "rr_range": "1:1.0-1:2.5",
      "risk_profile": "中等",
      "stop_loss_price": 181.2714,
      "strength_details": {
        "ma_score": 1,
        "atr_score": 2,
        "rsi_score": 0.5,
        "macd_score": 3,
        "volume_score": 2
      },
      "market_adjustment": 1,
      "risk_reward_ratio": 1.2,
      "stop_loss_percent": 4.1,
      "take_profit_price": 198.3975,
      "target_multiplier": 1.9,
      "technical_strength": 1.75,
      "take_profit_percent": 5
    },
    "positionPoints": 1.6,
    "stopLossPoints": 2.4,
    "diversification": {
      "score": 2,
      "details": {
        "method": "sector concentration proxy; no portfolio holdings used",
        "sector": "Health Care",
        "concentratedSectorPenalty": 0
      }
    },
    "riskRewardRatio": 1.2303675149115723,
    "stopLossPercent": 4.063826409102938,
    "diversificationPoints": 2
  },
  "total": {
    "max": 160,
    "result": 75.1,
    "formula": "score_with_momentum_v2 = main_score + momentum_5d_v2_score",
    "baseScore": 55.1,
    "modelVersion": "cursor_18_27_news_v2_160",
    "momentum5dScore": 20
  },
  "market": {
    "ma20": 178.6655,
    "ma50": 182.0142,
    "close": 188.95,
    "prevClose": 189.49,
    "avgVolume20": 897400,
    "volumeRatio": 1.65,
    "changePercent": -0.28
  },
  "sources": {
    "catalyst": "finnhub_news_keyword_model",
    "sentiment": "finnhub_news_keyword_model",
    "fundamentals": "fmp_stable",
    "institutional": null,
    "marketContext": "twelvedata+fred+database-backfill-market-proxy"
  },
  "barCount": 145,
  "momentum": {
    "max": 50,
    "result": 20,
    "details": {
      "ret_5d": 0.07394566329430474,
      "max_score": 50,
      "max_total": 50,
      "raw_total": 20,
      "vcp_bonus": 0,
      "vol_ratio": 1.6995607747795274,
      "ret_points": 12,
      "vol_points": 6,
      "range_ratio": 1.2744043771689109,
      "volat_points": 2,
      "day_range_pct": 0.02243983593543261,
      "model_version": "cursor_18_27_news_v2_160",
      "available_bars": 30,
      "breakout_points": 0,
      "partial_history": false,
      "pullback_points": 0,
      "breakout_vol_bonus": 0,
      "first_breakout_20d": false,
      "return_window_days": 5,
      "first_breakout_bonus": 0,
      "breakout_quality_points": 0
    },
    "formula": "Cursor_18.25 5D momentum v2 0-50",
    "modelVersion": "cursor_18_27_news_v2_160"
  },
  "scoreMax": 110,
  "composite": {
    "max": 160,
    "result": 75.1,
    "formula": "Cursor_18.25 ranking score v2 (score_with_momentum_v2)",
    "weights": [
      {
        "raw": 3.7,
        "label": "基本面",
        "weight": "5/110",
        "normalized": 74,
        "contribution": 3.7
      },
      {
        "raw": 11.6,
        "label": "資金流",
        "weight": "20/110",
        "normalized": 58,
        "contribution": 11.6
      },
      {
        "raw": 9,
        "label": "市場環境",
        "weight": "15/110",
        "normalized": 60,
        "contribution": 9
      },
      {
        "raw": 2,
        "label": "催化劑",
        "weight": "20/110",
        "normalized": 10,
        "contribution": 2
      },
      {
        "raw": 7.4,
        "label": "風險管理",
        "weight": "10/110",
        "normalized": 74,
        "contribution": 7.4
      },
      {
        "raw": 18.4,
        "label": "技術信號",
        "weight": "30/110",
        "normalized": 61.33,
        "contribution": 18.4
      },
      {
        "raw": 3,
        "label": "情緒分析",
        "weight": "10/110",
        "normalized": 30,
        "contribution": 3
      }
    ],
    "modelVersion": "cursor_18_27_news_v2_160"
  },
  "momentumMax": 50,
  "scoreStatus": "checked",
  "standard110": {
    "rating": "觀望",
    "result": 55.1,
    "details": [
      "基本面分析總分: 3.7/5分",
      "資金流分析總分: 11.6/20分",
      "市場環境分析總分: 9/15分",
      "催化劑分析: 2/20分",
      "風險管理總分: 7.4/10分",
      "技術信號分析總分: 18.4/30分",
      "情緒分析: 3/10分",
      "共振率(僅顯示不加分): 0%"
    ],
    "formula": "基本面5 + 資金流20 + 市場環境15 + 催化劑20 + 風險管理10 + 技術信號30 + 情緒10",
    "dimensionScores": {
      "催化劑": 2,
      "基本面": 3.7,
      "資金流": 11.6,
      "市場環境": 9,
      "情緒分析": 3,
      "技術信號": 18.4,
      "風險管理": 7.4
    },
    "dimensionDetails": {
      "催化劑": {
        "max": 20,
        "grade": "較差",
        "items": {
          "catalyst": {
            "score": 2,
            "details": {
              "source": "finnhub_news_keyword_model",
              "articleCount": 5,
              "catalystCount": 0
            }
          },
          "catalystPoints": 2
        }
      },
      "基本面": {
        "max": 5,
        "grade": "良好",
        "items": {
          "pbPoints": 0.4,
          "pePoints": 0.4,
          "epsPoints": 0.4,
          "roePoints": 0.4,
          "debtPoints": 0.4,
          "marginPoints": 0,
          "turnoverUsdM": 280.0239,
          "volumePoints": 0.5,
          "revenuePoints": 0.4,
          "dividendPoints": 0.3,
          "marketCapPoints": 0.5
        },
        "source": "fmp_stable"
      },
      "資金流": {
        "max": 20,
        "grade": "較差",
        "items": {
          "cmfPoints": 2.4,
          "mfiPoints": 2.4,
          "obvPoints": 0.8,
          "vwapPoints": 4,
          "institutional": {
            "score": 2,
            "details": {
              "source": "optional-neutral",
              "warning": {
                "code": "INSTITUTIONAL_DATA_OPTIONAL",
                "symbol": "US.DGX",
                "message": "Institutional ownership is unavailable; neutral 2/4 money-flow treatment used."
              },
              "optional": true,
              "holderCount": null,
              "holderPoints": 2,
              "top10ShareRatio": null,
              "concentrationPenalty": 0
            }
          },
          "institutionPoints": 2
        }
      },
      "市場環境": {
        "max": 15,
        "grade": "一般",
        "items": {
          "vix": {
            "score": 1.8,
            "details": {
              "source": "twelvedata+fred+database-backfill-market-proxy",
              "vixClose": 20.09
            }
          },
          "trend": {
            "score": 3.4,
            "details": {
              "qqq": {
                "ma20": 121.98465392607886,
                "ma50": 119.41417806680984,
                "name": "QQQ",
                "close": 120.02993738567542,
                "points": 1.4
              },
              "spy": {
                "ma20": 112.53347409917129,
                "ma50": 110.23726906087428,
                "name": "SPY",
                "close": 112.77327192153848,
                "points": 2
              },
              "source": "twelvedata+fred+database-backfill-market-proxy"
            }
          },
          "atrPct": 2.031913204551469,
          "atrPoints": 3,
          "cciPoints": 0.8,
          "vixPoints": 1.8,
          "marketTrendPoints": 3.4
        }
      },
      "情緒分析": {
        "max": 10,
        "grade": "較差",
        "items": {
          "sentiment": {
            "score": 3,
            "details": {
              "source": "finnhub_news_keyword_model",
              "articleCount": 5,
              "negativeHits": 0,
              "positiveHits": 1,
              "sentimentScoreRaw": 0.5
            }
          },
          "sentimentData": {
            "raw": [
              {
                "id": 140615840,
                "url": "https://finnhub.io/api/news?id=7a05145bb3efb646e93dac1f0de09e97ba5cca4144e93d6c03b19c31c4663b96",
                "image": "https://www.chartmill.com/images/uploads/Best_Dividend_500_264px_webp_9524a3945f.webp",
                "source": "ChartMill",
                "related": "DGX",
                "summary": "Quest Diagnostics (DGX) offers a 1.75% dividend yield with strong 7.42% annual growth. Featuring a sustainable 35% payout ratio and solid profitability, this stock balances reliable income with financial stability.",
                "category": "company",
                "datetime": 1781255440,
                "headline": "Quest Diagnostics Inc (NYSE:DGX): A Top Dividend Stock with Sustainable Income and Growth Potential"
              },
              {
                "id": 140525740,
                "url": "https://finnhub.io/api/news?id=b6e2bb6fd8edc2cbeb62be5f1f745e81049b3943c34ac194c362fabb2300bba5",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DGX",
                "summary": "Quest Diagnostics is in focus today as the latest update shows no changes to the current price targets set by covering analysts. Even without fresh commentary driving the story, the lack of adjustment itself can be useful context as you think about how the stock fits into your watchlist or portfolio. Read on to see how to monitor future shifts in the analyst narrative so you can stay on top of what changes and what stays the same. Wall Street's queuing for one rocket. While SpaceX counts down...",
                "category": "company",
                "datetime": 1780592890,
                "headline": "How The Quest Diagnostics (DGX) Investment Story Is Evolving Without New Analyst Price Target Changes"
              },
              {
                "id": 140460566,
                "url": "https://finnhub.io/api/news?id=5ee75f7ec4104dac24b2e468a1a398513a80b7f1280003cf01ea79f11012230e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DGX",
                "summary": "Quest Diagnostics (DGX) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.",
                "category": "company",
                "datetime": 1780070404,
                "headline": "Quest Diagnostics (DGX) Upgraded to Buy: Here's What You Should Know"
              },
              {
                "id": 140447040,
                "url": "https://finnhub.io/api/news?id=76fa090f28882e13396e37f10e3432b5d04a945f44a80319e578848ce3e5f679",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DGX",
                "summary": "Since November 2025, Quest has been in a holding pattern, posting a small return of 2.6% while floating around $194.06. The stock also fell short of the S&P 500’s 9.8% gain during that period.",
                "category": "company",
                "datetime": 1779989187,
                "headline": "3 Reasons to Sell DGX and 1 Stock to Buy Instead"
              },
              {
                "id": 140421419,
                "url": "https://finnhub.io/api/news?id=f865a9a57f7dd61d98179f034b0e6aea3ce3f70dd23d597cc203834196aec7f1",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DGX",
                "summary": "Here is how Quest Diagnostics (DGX) and DaVita HealthCare (DVA) have performed compared to their sector so far this year.",
                "category": "company",
                "datetime": 1779802801,
                "headline": "Are Medical Stocks Lagging  Quest Diagnostics (DGX) This Year?"
              }
            ],
            "raw_source": [
              {
                "id": 140668871,
                "url": "https://finnhub.io/api/news?id=08a165bfc9d22174df2b848db02f7eb78726040bc8f617e12f26030cdc3b4bd5",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DGX",
                "summary": "While Quest Diagnostics has lagged behind the S&P 500 Index over the past year, analysts are moderately optimistic about the stock’s prospects.",
                "category": "company",
                "datetime": 1781838718,
                "headline": "Is Quest Diagnostics Stock Underperforming the S&P 500?"
              },
              {
                "id": 140665236,
                "url": "https://finnhub.io/api/news?id=10a66dda14b20e65fc5be2ae6f7932dd68373d8b45a9c33eed65c7ea20cc6dbe",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DGX",
                "summary": "Labcorp Holdings has underperformed the Nasdaq over the past year, but analysts are highly optimistic about the stock’s prospects.",
                "category": "company",
                "datetime": 1781789504,
                "headline": "Is Labcorp Holdings Stock Underperforming the Nasdaq?"
              },
              {
                "id": 140662649,
                "url": "https://finnhub.io/api/news?id=a3ddc6fc60a25650a6a7b7ec00f1098550bdd259930a161fd2522e1fd6aaeaee",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DGX",
                "summary": "A common bacterial strain that lives naturally in people's guts can cause a dangerous or deadly infection for some, especially when it becomes multidrug-resistant and causes chronic urinary-tract infections (UTIs) in elderly women. But the extent of its effect on the broader population and its prevalence in the community was not well known – until now.",
                "category": "company",
                "datetime": 1781787420,
                "headline": "UTI-causing Bacteria Resistant to Current Drugs, Finds National Study by Hackensack Meridian CDI and Quest Diagnostics"
              },
              {
                "id": 140652802,
                "url": "https://finnhub.io/api/news?id=a2d1114a3464516682d5c89b546eb31ebc0c8cf8a5790a0e30e3eaea95e07646",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DGX",
                "summary": "Quest Diagnostics Incorporated (NYSE: DGX), a leader in diagnostic information services, announced today that it will report its second quarter 2026 financial results on Thursday, July 23, 2026, before the market opens. It will hold its quarterly conference call to discuss the results beginning at 8:30 a.m. Eastern Time on that day.",
                "category": "company",
                "datetime": 1781701200,
                "headline": "Quest Diagnostics to Release Second Quarter Financial Results on July 23, 2026"
              },
              {
                "id": 140645122,
                "url": "https://finnhub.io/api/news?id=02545c56786bbb69e32353ee74b7b0c8716b762e706b90b0f64b40239d51d26e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DGX",
                "summary": "Quest Diagnostics (NYSE: DGX), a leader in diagnostic information services, today unveiled its 2025 Corporate Responsibility Report.",
                "category": "company",
                "datetime": 1781614800,
                "headline": "Quest Diagnostics Unveils Achievements in Healthcare Access, Employee Engagement and Environmental Sustainability in 2025 Corporate Responsibility Report"
              },
              {
                "id": 140645123,
                "url": "https://finnhub.io/api/news?id=f6eb967deba60429c3484684beb7ee44db64e94e7fe5eb8e4629bd0c8f289fd2",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DGX",
                "summary": "GAITHERSBURG, Md., June 16, 2026--GeneDx today announced the appointment of Mark Gardner as President, effective June 15, 2026.",
                "category": "company",
                "datetime": 1781613000,
                "headline": "GeneDx Names Mark Gardner President to Lead Its Next Phase of Scale and Growth"
              },
              {
                "id": 140615840,
                "url": "https://finnhub.io/api/news?id=7a05145bb3efb646e93dac1f0de09e97ba5cca4144e93d6c03b19c31c4663b96",
                "image": "https://www.chartmill.com/images/uploads/Best_Dividend_500_264px_webp_9524a3945f.webp",
                "source": "ChartMill",
                "related": "DGX",
                "summary": "Quest Diagnostics (DGX) offers a 1.75% dividend yield with strong 7.42% annual growth. Featuring a sustainable 35% payout ratio and solid profitability, this stock balances reliable income with financial stability.",
                "category": "company",
                "datetime": 1781255440,
                "headline": "Quest Diagnostics Inc (NYSE:DGX): A Top Dividend Stock with Sustainable Income and Growth Potential"
              },
              {
                "id": 140594190,
                "url": "https://finnhub.io/api/news?id=fe13425cb83a2200bec8c0a082ede13f10cef8dcd706a56d10cff8412575574d",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DGX",
                "summary": "Quest Diagnostics, DaVita, LifeStance Health and Aveanna Healthcare are benefiting from telehealth, AI adoption and growing home-care demand.",
                "category": "company",
                "datetime": 1781097720,
                "headline": "Zacks Industry Outlook Highlights Quest Diagnostics, DaVita, LifeStance Health and Aveanna Healthcare"
              },
              {
                "id": 140581606,
                "url": "https://finnhub.io/api/news?id=9bb8e271a7af0c14ca05659cc4848cc2352964d67cf4361222aad63995e29041",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DGX",
                "summary": "An aging population and rising telehealth and AI adoption boost demand in the Zacks Medical - Outpatient and Home Healthcare industry. DGX, DVA, LFST and AVAH stand to benefit.",
                "category": "company",
                "datetime": 1781016000,
                "headline": "4 Outpatient Home Health Stocks Benefiting From Industry Trends"
              },
              {
                "id": 140535106,
                "url": "https://finnhub.io/api/news?id=c57369c47aa907aaf1780d15a262ad0b4f4f1dab02017c63aa94889e370381aa",
                "image": "https://www.chartmill.com/images/uploads/CM_Premarket_Movers_Small_free_90289f6b81.webp",
                "source": "ChartMill",
                "related": "DGX",
                "summary": "Before the US market kicks off on Friday, let's examine the pre-market session and unveil the notable performers among the S&P500 top gainers and losers.",
                "category": "company",
                "datetime": 1780662900,
                "headline": "Top S&P500 movers in Friday's pre-market session"
              },
              {
                "id": 140525740,
                "url": "https://finnhub.io/api/news?id=b6e2bb6fd8edc2cbeb62be5f1f745e81049b3943c34ac194c362fabb2300bba5",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DGX",
                "summary": "Quest Diagnostics is in focus today as the latest update shows no changes to the current price targets set by covering analysts. Even without fresh commentary driving the story, the lack of adjustment itself can be useful context as you think about how the stock fits into your watchlist or portfolio. Read on to see how to monitor future shifts in the analyst narrative so you can stay on top of what changes and what stays the same. Wall Street's queuing for one rocket. While SpaceX counts down...",
                "category": "company",
                "datetime": 1780592890,
                "headline": "How The Quest Diagnostics (DGX) Investment Story Is Evolving Without New Analyst Price Target Changes"
              },
              {
                "id": 140525741,
                "url": "https://finnhub.io/api/news?id=a1bf00dc6631b26eca5d16cb6f543b49929f4df34a2acc38cb31b2b6ca08fa8b",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DGX",
                "summary": "DaVita HealthCare (DVA) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.",
                "category": "company",
                "datetime": 1780587012,
                "headline": "DaVita HealthCare (DVA) Up 0.6% Since Last Earnings Report: Can It Continue?"
              },
              {
                "id": 140486850,
                "url": "https://finnhub.io/api/news?id=9aa04f5b5fbf5aa0c2ffc3af4c508d1720ce92f4d02c51a44b98134b51b03e09",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DGX",
                "summary": "EHC is expanding its rehabilitation network with a new 36-bed hospital in West Virginia.",
                "category": "company",
                "datetime": 1780315740,
                "headline": "Encompass Health to Expand WV Footprint With 36-Bed Bridgeport Unit"
              },
              {
                "id": 140460566,
                "url": "https://finnhub.io/api/news?id=5ee75f7ec4104dac24b2e468a1a398513a80b7f1280003cf01ea79f11012230e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DGX",
                "summary": "Quest Diagnostics (DGX) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.",
                "category": "company",
                "datetime": 1780070404,
                "headline": "Quest Diagnostics (DGX) Upgraded to Buy: Here's What You Should Know"
              },
              {
                "id": 140447040,
                "url": "https://finnhub.io/api/news?id=76fa090f28882e13396e37f10e3432b5d04a945f44a80319e578848ce3e5f679",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DGX",
                "summary": "Since November 2025, Quest has been in a holding pattern, posting a small return of 2.6% while floating around $194.06. The stock also fell short of the S&P 500’s 9.8% gain during that period.",
                "category": "company",
                "datetime": 1779989187,
                "headline": "3 Reasons to Sell DGX and 1 Stock to Buy Instead"
              },
              {
                "id": 140421419,
                "url": "https://finnhub.io/api/news?id=f865a9a57f7dd61d98179f034b0e6aea3ce3f70dd23d597cc203834196aec7f1",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DGX",
                "summary": "Here is how Quest Diagnostics (DGX) and DaVita HealthCare (DVA) have performed compared to their sector so far this year.",
                "category": "company",
                "datetime": 1779802801,
                "headline": "Are Medical Stocks Lagging  Quest Diagnostics (DGX) This Year?"
              },
              {
                "id": 140413445,
                "url": "https://finnhub.io/api/news?id=ae610d13ba08036a4003a9833ecc4cb745d5da2b4a568427191a590b2d4807f0",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DGX",
                "summary": "Quest Diagnostics is keeping analysts reasonably upbeat as steady execution and momentum continue supporting Wall Street confidence.",
                "category": "company",
                "datetime": 1779712356,
                "headline": "Quest Diagnostics Stock: Analyst Estimates & Ratings"
              },
              {
                "id": 140397951,
                "url": "https://finnhub.io/api/news?id=714544268cb0481d8b078b9c8724263249e73d28d3824cb2fc661958e6c22ccc",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DGX",
                "summary": "Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today doesn’t mean it will thrive tomorrow.",
                "category": "company",
                "datetime": 1779542215,
                "headline": "1 Profitable Stock to Own for Decades and 2 We Avoid"
              }
            ],
            "data_source": "finnhub_news_keyword_model",
            "article_count": 5,
            "negative_hits": 0,
            "positive_hits": 1,
            "recomputed_at_score": true,
            "sentiment_score_raw": 0.5,
            "source_article_count": 18,
            "discarded_article_count": 13
          },
          "sentimentPoints": 3
        }
      },
      "技術信號": {
        "max": 30,
        "raw": 18.4,
        "grade": "一般",
        "items": {
          "bbPoints": 3,
          "adxPoints": 3,
          "sarPoints": 2.4000000000000004,
          "vcpPoints": 0.9,
          "macdPoints": 4,
          "vcpPayload": {
            "vcp_pass": false,
            "vcp_score": 0.9,
            "vcp_reason": "站上MA50;升放量(近10日4日);Ready=N;Confirm=N",
            "vcp_metrics": {
              "up_days": 5,
              "vol_ref": 929630,
              "down_days": 4,
              "vcp_ready": false,
              "above_ma50": true,
              "avg_vol_10": 1013580,
              "avg_vol_20": 871990,
              "avg_vol_30": 929630,
              "range_pct_10": 0.10484265678750998,
              "range_pct_20": 0.10484265678750998,
              "range_pct_30": 0.10484265678750998,
              "up_expand_ok": true,
              "lookback_used": 79,
              "near_20d_high": true,
              "contraction_ok": false,
              "down_shrink_ok": false,
              "up_expand_days": 4,
              "breakout_20d_ok": false,
              "vol_ratio_10_30": 1.090304744898508,
              "dist_to_20d_high": 0.01068123929623347,
              "down_shrink_days": 2,
              "breakout_level_20d": 190.99001,
              "vcp_breakout_confirm": false,
              "contraction_ratio_10_30": 1
            },
            "vcp_name_en": "Volatility Contraction Pattern",
            "vcp_name_zh": "波動收縮形態",
            "vol_contraction": false
          },
          "kdjAdxPoints": 0.7,
          "rsiKdjPoints": 2.4,
          "volumeWeight": 2,
          "maCrossPoints": 0,
          "shortRsiPoints": 0.4,
          "shortMacdPoints": 0.4,
          "volConfirmPoints": 0,
          "volumePointsTechnical": 1.2
        }
      },
      "風險管理": {
        "max": 10,
        "grade": "良好",
        "items": {
          "position": {
            "score": 1.6,
            "details": {
              "atrPct": 2.031913204551469,
              "turnoverUsdM": 280.0239,
              "liquidityPoints": 0.6,
              "volatilityPoints": 1
            }
          },
          "rrPoints": 1.4,
          "stopLevels": {
            "symbol": "US.DGX",
            "rr_range": "1:1.0-1:2.5",
            "risk_profile": "中等",
            "stop_loss_price": 181.2714,
            "strength_details": {
              "ma_score": 1,
              "atr_score": 2,
              "rsi_score": 0.5,
              "macd_score": 3,
              "volume_score": 2
            },
            "market_adjustment": 1,
            "risk_reward_ratio": 1.2,
            "stop_loss_percent": 4.1,
            "take_profit_price": 198.3975,
            "target_multiplier": 1.9,
            "technical_strength": 1.75,
            "take_profit_percent": 5
          },
          "positionPoints": 1.6,
          "stopLossPoints": 2.4,
          "diversification": {
            "score": 2,
            "details": {
              "method": "sector concentration proxy; no portfolio holdings used",
              "sector": "Health Care",
              "concentratedSectorPenalty": 0
            }
          },
          "riskRewardRatio": 1.2303675149115723,
          "stopLossPercent": 4.063826409102938,
          "diversificationPoints": 2
        }
      }
    }
  },
  "modelVersion": "cursor_18_27_news_v2_160",
  "providerErrors": [],
  "rankingScoreMax": 160,
  "dataCompleteness": {
    "complete": true,
    "missingFields": [],
    "optionalInputs": [
      "institutionalData"
    ],
    "requiredInputs": [
      "fundamentals",
      "marketContext.VIX",
      "marketContext.SPY",
      "marketContext.QQQ",
      "catalystData",
      "sentimentData",
      "ATR",
      "sector"
    ],
    "optionalInputWarnings": []
  },
  "technicalIndicators": {
    "adx": 92.86,
    "atr": {
      "atr": 3.8393,
      "rule": "ATR / current price; lower volatility scores higher",
      "score": 6,
      "atr_pct": 2.03
    },
    "cci": {
      "rule": "Cursor_18.24 CCI bands",
      "level": "超買或超賣風險",
      "score": 2,
      "value": 177.5
    },
    "cmf": {
      "rule": "Cursor_18.24 CMF bands",
      "level": "輕微流入",
      "score": 6,
      "value": 0.1452
    },
    "kdj": {
      "d": 76.98,
      "j": 103.35,
      "k": 85.77,
      "rule": "Cursor_18.24 K/D cross",
      "score": 4,
      "signal": "金叉"
    },
    "mfi": {
      "rule": "Cursor_18.24 MFI bands",
      "level": "平衡",
      "score": 6,
      "value": 56.25
    },
    "obv": {
      "rule": "Cursor_18.24 recent_slope vs previous_slope",
      "score": 2,
      "trend": "資金流出",
      "value": -5923400,
      "recentSlope": -68500,
      "previousSlope": -15930
    },
    "rsi": 70.55,
    "sar": {
      "rule": "Cursor_18.24 Parabolic SAR",
      "score": 8,
      "trend": "上升",
      "value": 176.6378,
      "position": "SAR喺價下",
      "distancePct": 6.52,
      "previousTrend": "上升"
    },
    "ma50": 182.0142,
    "macd": {
      "macd": 1.820366665080769,
      "trend": "強烈看漲",
      "signal": -0.06379079292106576,
      "histogram": 1.8841574580018348
    },
    "vwap": {
      "rule": "Cursor_18.24 VWAP 20D consecutive close",
      "score": 10,
      "value": 179.7256,
      "position": "連續5日>VWAP",
      "consecutiveAbove": 5
    },
    "volume": {
      "rule": "Cursor_18.24 volume ratio",
      "level": "有量",
      "ratio": 1.65,
      "score": 6,
      "avgVolume": 897400,
      "currentVolume": 1482000
    },
    "derived": {
      "ma20": 178.6655,
      "ma50": 182.0142,
      "prevClose": 189.49,
      "avgVolume10": 1086900,
      "avgVolume20": 897400,
      "changePercent": -0.28,
      "avgVolumeForScore": 897400
    },
    "ma_cross": {
      "ma20": 178.6655,
      "ma50": 182.0142,
      "rule": "Cursor_18.24 MA20/MA50 cross",
      "cross": "熊勢",
      "score": 0,
      "prevMa20": 178.0255,
      "prevMa50": 181.8004,
      "spreadPct": 1.84,
      "isVolumeBreakout": false
    },
    "bollinger": {
      "lower": 167.7908,
      "upper": 189.5402,
      "position": "上半部"
    },
    "rsi_short": 92.35,
    "macd_short": {
      "macd": 0,
      "trend": "中性",
      "signal": 0,
      "histogram": 0
    },
    "volume_ratio": {
      "ratio": 1.65
    }
  }
}

Raw metrics JSON

{
  "close": 188.95,
  "volume": 1482000,
  "changePercent": -0.28
}

Scores are derived from cached daily market data using the Cursor_18.25 standard. Solorank.ai provides research support only and does not provide financial advice or buy/sell recommendations.